Back to Temasek Holdings (Private) Ltd Temasek Holdings (Private) Ltd

DNLIDNLI

Showing 9 of 32 quarters

Position history for Temasek Holdings (Private) LtdTemasek Holdings (Private) Ltd's holdings in Denali Therapeutics Inc.

Yes. Temasek Holdings (Private) holds 7,012,974 shares of DNLI (Denali Therapeutics), worth $145M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Temasek Holdings (Private) has held DNLI in every 13F on record since Q4 2018, 32 quarterly filings. DNLI is 0.4% of Temasek Holdings (Private)'s reported 13F portfolio.

Current Value

$145M

Current Shares

7M

Total Value Change

-$11.1M

Total Shares Change

+1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
7M
0.0%
$145M0.4%$20.67
0
2026-Q2
Unchanged
7M
0.0%
$180.4M0.5%$25.72
0
2026-Q1
Unchanged
7M
0.0%
$134.6M0.4%$20.02
0
2025-Q4
Increased
7M
+30.9%
$115.8M0.4%$16.41
46
2025-Q3
Unchanged
5.4M
0.0%
$77.8M0.3%$14.52
0
2025-Q2
Unchanged
5.4M
0.0%
$74.9M0.3%$14.10
0
2025-Q1
Unchanged
5.4M
0.0%
$72.8M0.3%$14.78
0
2024-Q4
Unchanged
5.4M
0.0%
$109.2M0.4%$20.38
0
2024-Q3
Decreased
5.4M
-6.1%
$156M0.6%$29.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used